Use of all-trans-retinoic acid [ATRA] as remission induction agent in acute promyelocytic leukemia [APL]
JPIMS-Journal of Pakistan Institute of Medical Sciences. 1995; 6 (1-2): 313-15
en Inglés
| IMEMR
| ID: emr-37850
ABSTRACT
We present here the details of treatment and hospital course of three patients with APL who were given ATRA therapy. Two complete remmissions and one partial remission were obtained. In addition, the coagulopathy present in one case was controlled easily. The mode of action and other features of ATRA therapy are discussed
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Tretinoina
/
Vitamina E
/
Leucocitos
Tipo de estudio:
Informe de Casos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
J. Pak. Inst. Med. Sci.
Año:
1995
Similares
MEDLINE
...
LILACS
LIS